Madopar HBS Capsule

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

levodopum, benserazidum

MAH:

Roche Pharma (Schweiz) AG

ATC_code:

N04BA02

INN:

levodopum, benserazidum

pharmaceutical_form:

Capsule

composition:

levodopum 100.0 mg, benserazidum 25.0 mg ut benserazidi hydrochloridum, hypromellosum, oleum vegetabile hydrogenatum, calcii hydrogenophosphas, mannitolum, povidonum K 30, talcum, magnesii stearas, Kapselhülle: E 132, E 171, gelatina, E 172 (flavum), Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (rubrum), pro capsula.

class:

B

therapeutic_group:

Synthetika

therapeutic_area:

Morbo Di Parkinson, Delle Gambe Senza Riposo-Syndrom

authorization_status:

zugelassen

authorization_date:

1987-06-18